Enterprise record

Crinetics Pharmaceuticals, Inc. logo

Crinetics Pharmaceuticals, Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:a6345ead-3e9e-41ff-9720-b7828407f15aVersion: public-1As of: unavailable

22 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 29, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 14, 2026

    Supports 3 claims
    • Legal Name: Crinetics Pharmaceuticals, Inc. · Claim reviewed: Sep 14, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 14, 2026
    • Published Fact: US · Claim reviewed: Sep 14, 2026

  2. SEC DEF 14A 0001658247-26-000030

    sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026

    Supports 12 claims
    • Leadership Role: Wendell Wierenga, Ph.D.: Chairperson of the Board of Directors · Claim reviewed: Sep 14, 2026
    • Leadership Role: Camille Bedrosian, M.D.: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: R. Scott Struthers, Ph.D.: President, Chief Executive Officer and Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Rogério Vivaldi Coelho, M.D.: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Stephanie S. Okey, M.S.: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Weston Nichols, Ph.D.: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Dana Pizzuti, M.D.: Chief Medical and Development Officer · Claim reviewed: Sep 14, 2026
    • Leadership Role: Isabel Kalofonos: Chief Commercial Officer · Claim reviewed: Sep 14, 2026
    • Leadership Role: Jeff Knight: Chief Operating Officer · Claim reviewed: Sep 14, 2026
    • Leadership Role: R. Scott Struthers, Ph.D.: President and Chief Executive Officer · Claim reviewed: Sep 14, 2026
    • Leadership Role: Stephen F. Betz, Ph.D.: Chief Scientific Officer · Claim reviewed: Sep 14, 2026
    • Leadership Role: Tobin Schilke: Chief Financial Officer · Claim reviewed: Sep 14, 2026

  3. DEF 14A crnx-20260429.htm

    sec proxy · Source published: Apr 29, 2026 · Retrieved: Sep 2, 2026

    Supports 7 claims
    • Leadership Role: Camille Bedrosian: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Caren Deardorf: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Matthew K. Fust: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Rogério Vivaldi Coelho: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Stephanie S. Okey: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Wendell Wierenga: Director · Claim reviewed: Sep 14, 2026
    • Leadership Role: Weston Nichols: Director · Claim reviewed: Sep 14, 2026